COS Funding Opportunities Search

COS Funding Opportunities™

COS Unique Id:	100771
Title:	RHS Financial Awards and Queen Elizabeth the Queen Mother Bursary, E.A. Bowles Memorial Bursary and Jimmy Smart Memorial Bursary
Sponsor:	Royal Horticultural Society (RHS)
Sponsor Type:	Other Nonprofit
Deadline:	June 30, 2008 September 30, 2008 December 24, 2008 March 31, 2009
Deadline Note:	Applications are considered four times a year and should be received at the latest by March 31, June 30, September 30, or December 24 for consideration at the meetings of the bursaries committee in May, August, November, and the following February respectively.
Eligibility:	Proposals to the RHS Financial Awards fund may be made by individuals or groups. General eligibility criteria for RHS bursaries are as follows: - Priority will be given to professional and student gardeners, but applications are invited from serious amateur gardeners, botanists, and related professions and institutions. - Applicants not resident in the British Isles may only apply for projects tenable in the British Isles (England, Scotland, Wales, Northern Ireland, Republic of Ireland, Channel Islands and the Isle of Man). - Applicants need not be members of the Royal Horticultural Society.
Citizenship or Residency:	Unrestricted
Activity Location:	Unrestricted
Requirements:	Graduate Student Ph.D./M.D./Other Professional Undergraduate Student Nonprofit Academic Institution
Abstract:	The RHS offers grants for horticultural projects. RHS Financial Awards are available for a wide range of projects associated with horticulture. Applications are invited, particularly from horticulturists, for financial grants for horticultural projects including study visits or working placements in gardens, plant exploration and study, taxonomy and research, attendance at conferences and distinct projects of educational or historical value. Additionally, RHS administers the following bursaries: - The Queen Elizabeth the Queen Mother Bursary is available annually, and is reserved for proposals of particular excellence. The bursaries committee gives preference to individual candidates aged between 20 and 35 years who are UK or Commonwealth citizens. - The E.A. Bowles Memorial Bursary, Ł500 every two years, is given for a project on one of the following: the work of E.A. Bowles; his garden at Myddelton House; or one of his particular horticultural interests, e.g., bulbs or alpines. The award is open to students and trainees in horticulture and relevant related topics, e.g., garden history and design. There are no age restrictions. - The Jimmy Smart Memorial Bursary, no more than Ł1,000 per year, is given to support a working (employed) gardener for travel and/or accommodation during visits overseas with the prime intention of seeing or studying plants and/or trees growing in their natural habitat. Other gardening-related travel may also be funded. Applications to visit Australia or New Zealand are particularly encouraged. Additional support may be offered to gardeners spending time in either of these countries. The award is open to experienced working gardeners in the British Isles, particularly those whose work includes responsibilities in relation to National Collections. There are no age restrictions.
Contact Name:	Secretary, RHS Bursaries Committee
Contact Address:	Education Department RHS Garden Wisley
Contact City:	Woking, Surrey
Contact Zip:	GU23 6QB
Contact Country:	United Kingdom
Contact Phone:	+44 (0) 1483-212380
Contact Fax:	+44 (0) 1483-212382
Contact Email:	bursaries@rhs.org.uk
URL for more information:	http://www.rhs.org.uk/learning/education/bursaries.asp
Date Last Revised:	April 17, 2008
URL from COS to Bookmark this record:	http://fundingopps.cos.com/cgi-bin/getRec?id=100771
Keywords:	Horticulture Plant Sciences Plant Taxonomy
Funding Type:	Meeting or Conference or Seminar Visiting Personnel Training, Scholarship, or Fellowship Research Program or Curriculum Development or Provision

COS Unique Id:	113491
Title:	Business line on Innovative Vector Control Interventions
Sponsor:	World Health Organization (WHO) Special Programme for Research and Training in Tropical Diseases (TDR)
Sponsor Type:	Multinational Organization
Deadline:	May 12, 2008
Deadline Note:	Required letters of intent must be submitted no later than May 12, 2008. The deadline for applications is June 27, 2008. This call is being reissued to address activities of malaria and Chagas disease vectors only. Following the review of the proposals received in response to the January 2008 call for applications, appropriate proposals for these two areas were not identified.
Upper Amount:	$200,000
Amount Note:	The grant proposals are funded for up to three years with a maximum annual budget of $200,000. Progress is evaluated each year and the grants may be renewed depending upon satisfactory report. Under Objective 2, one network is expected to be funded (preferably covering a broad range of different epidemiological and eco-climatic zones). The maximum amount of funding in U.S. dollars per network per year totals $200,000. Under Objective 3, one network is expected to be funded, and the maximum amount of funding in U.S. dollars per network per year totals $200,000.
Eligibility:	Research grant applications for projects to be conducted by networks in 2008 are invited from investigators worldwide. In order to promote collaborative research, each network proposal must reflect partnership between a minimum of three research institutions from endemic countries representing a broad range of different epidemiological and eco-climatic zones (multi-country based projects). In addition, the network could also involve investigators from non-endemic countries and all the researchers in the network would focus on a common goal in a complementary manner. A network should have only one principal investigator, co-principal investigators, and collaborators. Multi-country research grants that build on existing networks, collaboration with country disease control programmes, and with capacity building component in disease endemic countries are strongly encouraged.
Citizenship or Residency:	Unrestricted
Activity Location:	Unrestricted
Requirements:	Ph.D./M.D./Other Professional Academic Institution
Abstract:	*Rapid deadline notice. The application deadline for this opportunity will expire within four weeks of its inclusion in the COS database.* Vector-borne diseases that occur in more than 100 countries and affect about half of the world's population are emerging and resurging. This worsening situation reflecting an inadequate impact of control measures is due to various factors including poor implementation of interventions, limited resources, and development of resistance to insecticides in vector populations. It is generally recognized that effective prevention strategies can reverse this trend, and vector control is a key component of such strategies aiming at interrupting transmission. TDR Business Line on Innovative Vector Control Interventions research Scientific Advisory Committee re-invites a call for grant applications for collaborative research projects for two areas of activities regarding malaria and Chagas disease vectors. Genome sequencing of the main vectors of malaria, dengue, and Human African Trypanosomiasis (HAT) carries the promise of radically improved vector control methods, but this new approach will require careful and coordinated development, corroboration, and field evaluation. TDR's new vision and strategy is designed to foster an effective global research effort on infectious diseases of poverty where endemic countries play a pivotal role. The following three major strategic functions will guide the strategy: 1. Stewardship for infectious diseases of poverty 2. Empowerment of disease endemic countries' investigators and institutions 3. Research on neglected priorities The new strategy will contribute to the prevention of neglected vector-borne diseases through its Business Line on Innovative Vector Control Interventions research program whose goal is to develop and evaluate improved and innovative vector control methods for the prevention of neglected diseases. The specific objectives of the research program are - to promote the development and testing of new methods for improving Human African Trypanosomiasis (HAT) vector mass trapping systems, and support the generation and exploitation of Glossina genome sequence data; - to advance the development and evaluation of new and improved integrated methods for malaria and dengue vector control; and - to progress the development and evaluation of alternative methods for the prevention of re-infestation and the control of Chagas disease vectors. Under Objective 2: Advancing the development and evaluation of new and improved integrated methods for malaria and dengue vector control, activities include the development and evaluation of tailored methods for integrated malaria vector control through the optimization of current and/or novel interventions in field or semi-field situations by generating and exploiting knowledge on malaria transmission dynamics and vector biology, ecology, behaviour, and population genetics for better application and integration of existing proven control methods (such as insecticide treated materials (ITMs), indoor residual spraying of insecticides (IRS), or environmental management of vectors). End products of this research should be improved methods for integrated malaria vector control approaches with large-scale implementation potential developed and evaluated and guidance provided for their implementation. Under Objective 3: Progressing the development and evaluation of improved and new methods for Chagas disease vector control, applicants should set up a research network for development and field evaluation of new control approaches against Chagas disease vectors in domestic, peridomestic, and sylvatic situations based on methods including (but not limited to) biological control and exploitation of triatomine behaviour and habitat manipulation. The network should preferably cover the three different main Latin-American regions and their vector species. End products of this project should be new methods for Chagas disease vector control with large-scale implementation potential developed and evaluated and guidance provided for their implementation.
Contact Name:	Dr. Yeya T. Toure
Contact Address:	Special Programme for Research & Training in Tropical Diseases (TDR) World Health Organization
Contact City:	1211 Geneva 27
Contact Country:	Switzerland
Contact Phone:	41 22 791 3251
Contact Fax:	41 22 791 4854
Contact Email:	tourey@who.int
URL for more information:	http://www.who.int/tdr/grants/grants/bl5_research_grant2.htm
Date Last Revised:	April 18, 2008
URL from COS to Bookmark this record:	http://fundingopps.cos.com/cgi-bin/getRec?id=113491
Keywords:	Infectious Diseases or Agents
Funding Type:	Research Program or Curriculum Development or Provision

COS Unique Id:	113492
Title:	Grand Challenges Explorations Grants
Sponsor:	Gates Foundation, Bill and Melinda Grants
Sponsor Type:	Private Foundation
Deadline:	May 30, 2008
Deadline Note:	Applications are due by the deadline date. Pre-registration is required by May 15, 2008.
Amount Note:	Initial grants will be awarded multiple times per year at approximately $100,000 each. Additional funding of $1 million or more will be available for projects that show promise.
Eligibility:	In order to register and apply, applicants must be affiliated with an organization.
Citizenship or Residency:	Unrestricted
Activity Location:	Unrestricted
Requirements:	Ph.D./M.D./Other Professional
Abstract:	The foundation is accepting grant proposals for the first round of Grand Challenges Explorations, a $100 million initiative to encourage bold and unconventional global health solutions. One of the primary objectives of this grant program is to involve scientists around the world who don't typically work in global health. This includes innovators in Africa, Asia, and other parts of the developing world; those from complementary disciplines and in the private sector; and young investigators. The first four topic areas for which proposals will be accepted are - creating new ways to protect against infectious diseases, including alternatives to traditional vaccination; - creating new drugs and delivery systems to limit the emergence of resistance from developing in the disease-causing agent; - creating new ways to prevent or cure HIV infection that fall outside current research on vaccines, anti-retroviral drugs, and other biomedical and behavior-change strategies; and - exploring the basis for latency in TB, with the goal of discovering new ways to identify and eliminate latent infection, and break the cycle of TB transmission.
Contact Address:	Bill & Melinda Gates Foundation P.O. Box 23350
Contact City:	Seattle
Contact State:	WA
Contact Zip:	98102
Contact Country:	USA
Contact Phone:	+1 (206) 709-3400
Contact Email:	GCExplorations@gatesfoundation.org
URL for more information:	http://www.gcgh.org/explorations/Pages/Introduction.aspx
Date Last Revised:	April 16, 2008
URL from COS to Bookmark this record:	http://fundingopps.cos.com/cgi-bin/getRec?id=113492
Keywords:	Infectious Diseases or Agents International Health Tropical Medicine Tuberculosis
Funding Type:	Program or Curriculum Development or Provision

COS Unique Id:	113495
Title:	Immune Mechanisms of Virus Control (U01/U19)
Sponsor:	Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID)
Sponsor Type:	Federal, U.S.
Deadline:	August 18, 2008
Deadline Note:	An optional letter of intent is due July 18, 2008. This opportunity will expire on August 19, 2008. Resubmission and renewal applications are not permitted in response to this FOA.
Upper Amount:	$7,500,000
Amount Note:	This FOA will utilize the Cooperative Agreement (U01) and multi-project Cooperative Agreement (U19) grant mechanisms. It is anticipated that $14 million per year will be available for 7-15 new awards in FY 2009. An additional $1 million will be available in a Discretionary Fund to support exploratory pilot research projects that propose projects that capitalize on emerging opportunities. The total project period for an application submitted in response to this FOA may not exceed five years. Although the size of award may vary with the scope of research proposed, direct costs (excluding third party facilities and administrative) are limited to $500,000 per year for U01 grants, and $1.5 million per year for U19 grants. This program does not require cost sharing.
Eligibility:	Eligible applicants include institutes of higher education; nonprofits, for-profits, and small businesses; state and local governments; eligible agencies of the federal government; faith-based or community-based organizations; and non-domestic organizations.
Citizenship or Residency:	Unrestricted
Activity Location:	Unrestricted
Requirements:	Small Business Ph.D./M.D./Other Professional Commercial Government Nonprofit Academic Institution
Abstract:	NIAID invites new applications from single institutions and consortia of institutions to participate in this program. The goals of this initiative are to establish a network of synergistic research teams focused on basic immunological parameters of virus infection, mechanisms of virus-induced inflammation, and protective vaccination; and to discover and define novel basic immune mechanisms for controlling virus infections that will lead to new potential targets for developing future vaccines and therapeutics. This FOA represents the second phase of the NIAID Immune Mechanisms of Virus Control Program (IMVC). The first phase was awarded as exploratory R21 grants in fiscal year 2007 (RFA-AI-07-008). All qualified investigators are invited to apply; prior funding under the first phase or through NIAID or NIH is not required. This FOA will support studies on the immunological parameters of virus infection and vaccination that are important for understanding the key molecular and cellular mechanisms involved in the natural control of infection, the induction of protective immunity by vaccination, or the immune-mediated processes that cause pathology after virus infection or vaccination. All applications must propose studies on at least one of the NIAID Category A, B, or C or other Emerging/Re-emerging viruses of concern to human health (http://www3.niaid.nih.gov/research/topics/emerging/list.htm). In addition, studies on other viruses that pose serious threats to human health may be proposed. However, at least one of the specific aims in U01 grants and one of the projects proposed in U19 grants must be solely dedicated to viruses on the list of NIAID Category A, B, or C or other Emerging/Re-emerging viruses. HIV studies are excluded from this FOA. The goal of the program is to discover and define novel basic immune mechanisms that provide a more sophisticated understanding of the immune response to virus infection, and provide potential new targets for future vaccine and therapeutic drug development. It is not the purpose of this program to apply currently accepted immunological concepts to the development of improved anti-virus vaccines or therapies. For example, conventional antibody measurements used to test new vaccine candidates would not be considered responsive in the absence of studies on immune mechanisms of antibody protection.
Contact Name:	Michael Fato
Contact Address:	Division of Extramural Activities NIAID Room 2123, MSC-7614 6700B Rockledge Drive
Contact City:	Bethesda
Contact State:	Maryland
Contact Zip:	20892-7614
Contact Country:	United States
Contact Phone:	+1 (301) 402-6581
Contact Fax:	+1 (301) 493-0597
Contact Email:	mf59e@nih.gov
URL for more information:	http://grants1.nih.gov/grants/guide/rfa-files/RFA-AI-08-013.html
Date Last Revised:	April 17, 2008
URL from COS to Bookmark this record:	http://fundingopps.cos.com/cgi-bin/getRec?id=113495
Keywords:	Immune System Viral Infections Virology
Sponsor Reference No:	RFA-AI 08-013
Funding Type:	Collaboration or Cooperative Agreement Research

COS Unique Id:	113496
Title:	Microbicide Innovation Program (MIP IV) (R21/R33)
Sponsor:	Department of Health and Human Services (HHS) National Institutes of Health (NIH)
Sponsor Type:	Federal, U.S.
Deadline:	July 25, 2008
Deadline Note:	The opening date is May 25, 2008. An optional letter of intent is due June 25, 2008. This opportunity will expire on July 26, 2008. Applications for R21 support alone are not accepted under this FOA. Resubmission applications must include an introduction addressing the previous peer review critiques (Summary Statement). Up to two resubmissions (formerly "revisions/amendments") of a previously reviewed MIP I (in response to RFA-AI-06-005), MIP II (in response to RFA-AI-06-042) or MIP III (in response to RFA-AI-07-034) exploratory/developmental grant application may be submitted. The Phased Innovation Award (R21/R33) is not renewable and renewal applications will not be accepted.
Amount Note:	This FOA will utilize the NIH R21/R33 Phased Innovation Award to support innovative exploratory and developmental research. Under the R21 phase, research is initiated and carried out through a milestone-driven process to establish the feasibility of new microbicides, microbicide strategies and support technologies. The R33 phase then provides the support required to translate the innovation discoveries into the preclinical or clinical development pipeline. The NIAID intends to commit approximately $2,000,000 in FY 2009 to fund 10 to 15 grants. The total project period for an application submitted in response to this funding opportunity may not exceed five years. Awards will support milestone-driven exploratory/feasibility "proof-of-concept" studies (two-year R21 phase), with possible rapid transition to expanded development (three-year R33 phase). Direct costs are limited to $275,000 over the R21 two-year period, with a maximum of $200,000 in direct costs allowed in any single year. The R33 award phase will be limited to $300,000 in direct costs per annum. The NIAID anticipates that a maximum of fifty percent (50 percent) of the funded R21 phase awards will progress to the R33 award. This program does not require cost sharing.
Eligibility:	Applications may be submitted by domestic or foreign, for-profit or nonprofit organizations and public or private institutions, such as universities, colleges, hospitals, and laboratories; units of state and local governments; eligible agencies of the federal government; and faith-based or community-based organizations.
Citizenship or Residency:	Unrestricted
Activity Location:	Unrestricted
Requirements:	Small Business Ph.D./M.D./Other Professional Commercial Government Nonprofit Academic Institution
Abstract:	This FOA, issued by the National Institute of Allergy and Infectious Disease (NIAID) and National Institute of Mental Health (NIMH), and supported by the Office of Research in Women's Health (ORWH), solicits Research Project Grant (R21/R33) applications in the field of topical microbicides to advance - development of new microbicide approaches and additional rational targets through preclinical and basic research; - discovery and characterization of microbicides (singly or in combinations) directed against HIV or sexually transmitted infections (STIs) that are linked to HIV acquisition; - emerging technologies or models that contribute to the development of new and/or more efficient ways of assessing microbicide safety, efficacy and acceptability; - design of complex prevention strategies that incorporate vaginal, rectal, and/or penile applied microbicides in the context of mucosally active vaccines; and - development of behavioral and social tools that address product acceptability, initiation, and potential for sustained use. Phase I, II or III clinical trials proposed specifically to advance an IND for a microbicide or microbicide strategy or "first-time-in human" studies will not be supported. However, clinical research that uses clinical specimens or uses collection of behavioral or social data may be supported under this FOA. Applicants are strongly urged to discuss any proposal containing clinical elements with program staff prior to submission. Additional Contact: Rita Sisco Division of Extramural Activities National Institute of Mental Health Room 6115, MSC 9605 6001 Executive Boulevard Bethesda, MD 20892-9605 Phone +1 (301) 480-1956 Fax +1 (301) 443-6885 siscor@mail.nih.gov
Contact Name:	Quadira Huff
Contact Address:	Division of Extramural Activities NIAID Room 2231, MSC-7614 6700B Rockledge Drive
Contact City:	Bethesda
Contact State:	Maryland
Contact Zip:	20892-7614
Contact Country:	United States
Contact Phone:	+1 (301) 451-2696
Contact Fax:	+1 (301) 493-0597
Contact Email:	huffq@mail.nih.gov
URL for more information:	http://grants1.nih.gov/grants/guide/rfa-files/RFA-AI-08-016.html
Date Last Revised:	April 17, 2008
URL from COS to Bookmark this record:	http://fundingopps.cos.com/cgi-bin/getRec?id=113496
Keywords:	HIV Microbial Pathogenesis Sexually Transmitted Diseases
Sponsor Reference No:	RFA-AI-08-016
Funding Type:	Research

COS Unique Id:	113497
Title:	Modeling of Infectious Disease Agent Study Information Technology Resource (U24)
Sponsor:	Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS)
Sponsor Type:	Federal, U.S.
Deadline:	July 1, 2008
Deadline Note:	A non-required letter of intent is due June 2, 2008. This opportunity will expire on July 2, 2008. Resubmission applications are not permitted in response to this FOA; all applications must be new. Renewal applications of awards responsive to RFA-GM-03-008 and RFA-GM-05-011 are permitted in response to this FOA.
Upper Amount:	$2,500,000
Amount Note:	This FOA will utilize the Cooperative Agreement (U01) grant mechanism. NIGMS has committed to making four awards not to exceed total costs of 3 million dollars in FY 2009. The total project period for an application submitted in response to this funding opportunity may not exceed five years. Direct costs may not exceed $500,000, exclusive of facilities and administrative costs of subcontracts, in any single year. This program does not require cost sharing.
Eligibility:	Eligible applicants include institutions of higher education; nonprofits, for-profits, and small businesses; eligible agencies of the federal government; and non-domestic organizations.
Citizenship or Residency:	Unrestricted
Activity Location:	Unrestricted
Requirements:	Small Business Ph.D./M.D./Other Professional Commercial Government Nonprofit Academic Institution
Abstract:	This FOA solicits Cooperative Agreement (U01) applications from institutions and organizations that propose to provide the U.S. scientific and public health communities better resources, knowledge, and tools to improve their ability to identify and prevent the spread of diseases resulting from the emergence or intentional release of pathogens and their products. Research projects will become part of the Models of Infectious Disease Agent Study (MIDAS) Network. The MIDAS Network will consist of a centralized information technology resource (announced separately), a Centers of Excellence component (announced separately) and, with this announcement, the continuation of a network of multidisciplinary scientists conducting computational and mathematical research to improve the ability to detect, control, and prevent emerging infectious diseases caused by naturally occurring or intentionally released pathogens, including those relevant to biodefense. Projects funded through MIDAS use existing sequence, genetic, epidemiological, clinical, climate, etc. information to conduct research. They will not generate primary data using MIDAS funding, with the exception of synthesized data.
Contact Name:	Ms. Grace Olascoaga
Contact Address:	Grants Administration Branch NIGMS Building 45, Room 2AN 32C 45 Center Drive MSC6200
Contact City:	Bethesda
Contact State:	Maryland
Contact Zip:	20892
Contact Country:	United States
Contact Phone:	+1 (301) 594-5520
Contact Fax:	+1 (301) 480-2554
Contact Email:	olascoag@mail.nih.gov
URL for more information:	http://grants1.nih.gov/grants/guide/rfa-files/RFA-GM-09-001.html
Date Last Revised:	April 17, 2008
URL from COS to Bookmark this record:	http://fundingopps.cos.com/cgi-bin/getRec?id=113497
Keywords:	Disease Model Infectious Diseases or Agents
Sponsor Reference No:	RFA-GM-09-001
Funding Type:	Collaboration or Cooperative Agreement Research

COS Unique Id:	1794
Title:	Short-Term Fellowship
Sponsor:	Human Frontier Science Program (HFSP) Organization
Sponsor Type:	Other Nonprofit
Deadline Note:	Continuous. Applications may be submitted at any time of the year.
Amount Note:	Short-Term Fellowships are awarded for periods of two weeks to three months. Short-Term Fellowships will cover round-trip travel expenses for one trip (the shortest route, the most economical means of travel) and living expenses at the following daily rates: - Australia: 102 AUD - Austria: 70 Euro - Belgium: 70 Euro - Canada: 90 CAD - Denmark: 630 DKK - Finland: 70 Euro - France: 70 Euro - Germany: 70 Euro - Italy: 62 Euro - India: 2,200 INR - Ireland: 75 EUR - Japan: 11,440 JPY - Korea: 55,000 KRW - Luxembourg: 73 Euro - New Zealand: 125 NZD - Norway: 700 NOK - Spain: 57 Euro - Sweden: 761 SEK - Switzerland: 140 CHF - The Netherlands: 70 Euro - United Kingdom: 46 GBP - United States of America: 74 USD
Eligibility:	A scientist from one of the supporting countries may apply for a Short-Term Fellowship to work in a research institution in any other country. A candidate from a non-supporting country may apply to work in a research institution in any of the supporting countries. Applicants must have a research doctorate (Ph.D.) or a doctoral degree with equivalent experience in research at the time of application. Preference will be given to young investigators at an early stage of their careers. Doctoral students may apply only under certain conditions. Applicants must have adequate language skills to carry out their proposed research at the host institution.
Citizenship or Residency:	Unrestricted
Activity Location:	Unrestricted
Requirements:	Graduate Student Ph.D./M.D./Other Professional
Abstract:	The Human Frontier Science Program (HFSP) supports basic research focused on elucidating the complex mechanisms of living organisms. The program emphasizes novel, innovative and interdisciplinary approaches to basic science that involve scientific exchanges across national boundaries. In particular, HFSP encourages research into biological problems involving approaches and knowledge from different disciplines such as chemistry, physics, mathematics, computer sciences, engineering or materials sciences because significant new ideas, techniques and discoveries often arise at the boundaries between disciplines. Short-Term Fellowships are reserved for those who wish to work for a short period in a laboratory in another country, in order to learn or develop new techniques, to use instruments or technology not available in their own country, to establish collaborations in a new area of research rather than ongoing projects, or to obtain pilot results to establish a new international collaboration. The HFSPO supporting countries include Australia, Austria, Belgium, Bulgaria, Canada, Cyprus (EU part only), the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, India, the Republic of Ireland, Italy, Japan, the Republic of Korea, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, New Zealand, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, the United Kingdom and the United States of America. The scope of HFSP funding ranges from biological functions at the molecular and cellular level up to biological systems including cognitive functions. Within this broad area, all levels of analysis are supported, from studies on genes and individual molecules, intracellular networks, intercellular associations in tissues and organs, to networks underlying complex functions of entire organisms. However, projects that involve only large-scale, systematic genome mapping, applied research (e.g. clinical) or pure "omics"-type projects are not eligible to receive HFSP funding. The HFSP does not support projects aimed specifically at developing methods of treatment and diagnosis. Studies related to disease are only considered if they allow new insights into fundamental biological mechanisms. Proposals directly concerned with agricultural or environmental problems (crop yield, bioremediation) or studies at the population or ecosystem level are not supported. The HFSP views interdisciplinary approaches as being necessary for addressing the scientific questions that it supports, and that fellows should receive broad research training. Thus, applicants for Short-Term Fellowships should obtain training or establish collaborations in a new research field. Individuals working in physics, chemistry, mathematics, computer science or engineering are encouraged to utilize HFSP fellowships to obtain training or establish new collaborations in the life sciences.
Contact Name:	Fellowships Coordinator
Contact Address:	International Human Frontier Science Program Organization 12, quai Saint-Jean B.P. 10034
Contact City:	67080 Strasbourg Cedex
Contact Country:	France
Contact Phone:	+33 (0) 3-88-21-51-34
Contact Fax:	+33 (0) 3-88-32-88-97
Contact Email:	fellow@hfsp.org
URL for more information:	http://www.hfsp.org/how/appl_forms_STF.php
Date Last Revised:	April 17, 2008
URL from COS to Bookmark this record:	http://fundingopps.cos.com/cgi-bin/getRec?id=1794
Keywords:	Biological Sciences Brain Brain Development Cognitive Development or Processes Human Learning and Memory Language Acquisition and Development Molecular Recognition Morphogenesis
Funding Type:	Collaboration or Cooperative Agreement Visiting Personnel Equipment or Materials Acquisition or Facility Use

COS Unique Id:	2606
Title:	Production and Post-Harvest Research Projects
Sponsor:	American Floral Endowment (AFE)
Sponsor Type:	Other Nonprofit
Deadline:	June 1, 2008
Deadline Note:	Pre-proposal applications are due by June 1.
Amount Note:	The award amount is unspecified. The endowment funds one- to three-year-long projects. Grants will be paid to each team member and/or institution separately.
Eligibility:	Projects with either a single researcher or multiple researchers at the same or different institutions are considered. When two or more researchers are included, a "Team Leader" must be designated to coordinate the implementation and reporting of the project. Grants will be paid to each team member and/or institution separately. The board of trustees recognizes the need for young researchers to be able to establish their careers in floricultural research. Thus, they give special consideration to these researchers who submit well-written pre-proposals and full proposals that specifically address industry needs. To meet these criteria, the board of trustees urges these researchers to contact industry representatives prior to developing their pre-proposals. This will aid identifying researchable problems.
Citizenship or Residency:	Unspecified
Activity Location:	Unrestricted
Requirements:	Ph.D./M.D./Other Professional
Abstract:	The AFE funds production and post-harvest scientific research projects to provide essential knowledge for a growing and dynamic floricultural industry. Periodically, the AFE conducts industry surveys to assist the board of trustees in identifying current and future problems faced by the floral industry. The feedback helps to focus funding efforts aimed at solving all industry problems. The basic research priorities, listed below, are focused on all floricultural crops, e.g., bedding plants, fresh cut flowers, fresh cut greens, flowering potted plants, and foliage plants: 1. Plant breeding and genetic engineering of floricultural crops 2. Management protocols for floricultural crops 3. Management systems for diseases for floriculture crops 4. Management systems for insects affecting floricultural crops 5. Post-harvest management systems for floriculture crops
Contact Address:	American Floral Endowment P.O. Box 945
Contact City:	Edwardsville
Contact State:	Illinois
Contact Zip:	62025
Contact Country:	United States
Contact Phone:	+1 (618) 692-0045
Contact Fax:	+1 (618) 692-4045
Contact Email:	afe@endowment.org
URL for more information:	http://www.endowment.org/scientific-research/
Date Last Revised:	April 14, 2008
URL from COS to Bookmark this record:	http://fundingopps.cos.com/cgi-bin/getRec?id=2606
Keywords:	Crop Science Floriculture Horticulture Plant Diseases or Pathology
Funding Type:	Research

COS Unique Id:	81963
Title:	NIH Support for Conferences and Scientific Meetings - R13/U13
Sponsor:	Department of Health and Human Services (HHS) National Institutes of Health (NIH)
Sponsor Type:	Federal, U.S.
Deadline:	August 12, 2008 December 12, 2008 April 12, 2009
Deadline Note:	The application receipt dates are April 12, August 12, and December 12, annually. This program announcement expires May 8, 2011. Applicants may submit more than one application, provided that each application is scientifically distinct. NIH Institutes and Centers (ICs) will not accept multiple applications for a single scientific meeting. Applicants may submit a resubmission application, but such application must include an introduction (limited to one page) addressing the previous peer review critique (Summary Statement). Resubmissions require a new permission-to-submit letter from an NIH IC.
Amount Note:	This FOA will utilize the NIH conference grant (R13) and conference cooperative agreement (U13) award mechanisms. Because the nature and scope of the proposed activities will vary from application to application, it is anticipated that the size and duration of each award will also vary.
Eligibility:	Applications may be submitted by domestic for-profit or nonprofit organizations and public or private institutions, such as universities, colleges, hospitals, and laboratories; units of state and local governments; eligible agencies of the federal government; and faith-based or community-based organizations. Foreign institutions are not eligible to apply for conference grant support. An international conference can be supported through the U.S. representative organization of an established international scientific or professional society.
Citizenship or Residency:	United States
Activity Location:	Unrestricted
Requirements:	Small Business Ph.D./M.D./Other Professional Commercial Government Nonprofit Academic Institution
Abstract:	The purpose of the program is to support high quality conferences and scientific meetings that are relevant to the NIH's scientific mission and to the public health. The NIH recognizes the value to members of the research community and all other interested parties of supporting such forums. A conference or scientific meeting is defined as an open gathering, symposium, seminar, scientific meeting, workshop or any other organized, formal meeting where persons assemble to coordinate, exchange, and disseminate information and/or to explore or clarify a defined subject, problem, or area of knowledge. Institutes and centers participating in this program are the National Institute on Aging (NIA), National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Cancer Institute (NCI), National Institute of Child Health and Human Development (NICHD), National Center for Complementary and Alternative Medicine (NCCAM), National Institute on Deafness and Other Communication Disorders (NIDCD), National Institute of Dental and Craniofacial Research (NIDCR), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute on Drug Abuse (NIDA), National Institute of Environmental Health Sciences (NIEHS), National Eye Institute (NEI), National Institute of General Medical Sciences (NIGMS), National Heart, Lung, and Blood Institute (NHLBI), National Human Genome Research Institute (NHGRI), National Institute of Mental Health (NIMH), National Institute of Neurological Disorders and Stroke (NINDS), National Library of Medicine (NLM), National Center for Research Resources (NCRR), Office of Research on Women's Health (ORWH), Office of Behavioral and Social Sciences Research (OBSSR), Office of Rare Diseases (ORD), and Office of Dietary Supplements (ODS).
Contact Name:	Linda M. Stecklein, NIH Conference Grant Coordinator
Contact Address:	National Institutes of Health Office of Extramural Research 6705 Rockledge Drive, Room 3524
Contact City:	Bethesda
Contact State:	Maryland
Contact Zip:	20892
Contact Country:	United States
Contact Phone:	+1 (301) 402-7989
Contact Fax:	+1 (301) 480-0146
Contact Email:	LS41G@nih.gov
URL for more information:	http://grants1.nih.gov/grants/guide/pa-files/PA-08-149.html
Date Last Revised:	April 17, 2008
URL from COS to Bookmark this record:	http://fundingopps.cos.com/cgi-bin/getRec?id=81963
Keywords:	Health and Medicine Public Health Social Sciences
Sponsor Reference No:	PA-08-149
Funding Type:	Collaboration or Cooperative Agreement Meeting or Conference or Seminar